PL358580A1 - Novel compounds - Google Patents

Novel compounds

Info

Publication number: PL358580A1
Authority: PL; Poland
Prior art keywords: novel compounds; novel; compounds
Prior art date: 2000-04-27

Application number

PL01358580A

Other languages

Polish (pl)

Inventor

Pankaj Agarwal

Paul R. Murdock

Safia K. Rizvi

Randall F. Smith

Zhaoying Xiang

Karen S. Kabnick

Ying Ta Lai

Qing Xie

Original Assignee

Smithkline Beecham Corporation

Smithkline Beecham P.L.C.

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2000-04-27

Filing date

2001-04-26

Publication date

2004-08-09

2001-04-26 Application filed by Smithkline Beecham Corporation, Smithkline Beecham P.L.C. filed Critical Smithkline Beecham Corporation

2004-08-09 Publication of PL358580A1 publication Critical patent/PL358580A1/en

Links

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H21/00—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
- C07H21/04—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids with deoxyribosyl as saccharide radical
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Organic Chemistry (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
General Chemical & Material Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Animal Behavior & Ethology (AREA)
Chemical Kinetics & Catalysis (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Molecular Biology (AREA)
Genetics & Genomics (AREA)
Biochemistry (AREA)
Biomedical Technology (AREA)
Zoology (AREA)
Neurosurgery (AREA)
Reproductive Health (AREA)
Wood Science & Technology (AREA)
Biotechnology (AREA)
Neurology (AREA)
Biophysics (AREA)
Diabetes (AREA)
Rheumatology (AREA)
Gynecology & Obstetrics (AREA)
Pregnancy & Childbirth (AREA)
Heart & Thoracic Surgery (AREA)
Endocrinology (AREA)
Pulmonology (AREA)
Toxicology (AREA)
Communicable Diseases (AREA)
Gastroenterology & Hepatology (AREA)
Hematology (AREA)
Immunology (AREA)
Pain & Pain Management (AREA)
Cardiology (AREA)

PL01358580A 2000-04-27 2001-04-26 Novel compounds PL358580A1 (en)

Applications Claiming Priority (4)

Application Number	Priority Date	Filing Date
US19996300P	2000-04-27	2000-04-27
US20333600P	2000-05-11	2000-05-11
US20708700P	2000-05-25	2000-05-25
US20754600P	2000-05-26	2000-05-26

Publications (1)

Publication Number	Publication Date
PL358580A1 true PL358580A1 (en)	2004-08-09

Family

ID=27498358

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
PL01358580A PL358580A1 (en)	2000-04-27	2001-04-26	Novel compounds

Country Status (15)

Country	Link
EP (1)	EP1276755A4 (en)
JP (1)	JP2003530869A (en)
KR (1)	KR20030032940A (en)
CN (1)	CN1439017A (en)
AU (1)	AU2001257265A1 (en)
BR (1)	BR0110402A (en)
CA (1)	CA2407449A1 (en)
CZ (1)	CZ20023548A3 (en)
HK (1)	HK1053840A1 (en)
HU (1)	HUP0300595A3 (en)
IL (1)	IL152416A0 (en)
MX (1)	MXPA02010692A (en)
NO (1)	NO20025151L (en)
PL (1)	PL358580A1 (en)
WO (1)	WO2001081363A1 (en)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6558936B1 (en) *	1999-10-01	2003-05-06	Millennium Pharmaceuticals, Inc.	Human lipase proteins, nucleic acids encoding them, and uses of both of these
US6630335B1 (en)	2000-02-11	2003-10-07	Millennium Pharmaceuticals, Inc.	14171 protein kinase, a novel human protein kinase and uses thereof
NZ523122A (en) *	2000-06-22	2004-06-25	Smithkline Beecham Corp	Polypeptides and polynucleotides and methods of identifying agonists and antagonists in relation to treatment of diseases
WO2002002772A2 (en) *	2000-06-30	2002-01-10	Incyte Genomics, Inc.	Human extracellular matrix (ecm)-related tumor marker
WO2002012330A2 (en) *	2000-08-04	2002-02-14	Zymogenetics, Inc.	Human secreted protein, zzp1
US7358353B2 (en)	2000-08-22	2008-04-15	Agensys, Inc.	Nucleic acid and corresponding protein named 158P1D7 useful in the treatment and detection of bladder and other cancers
WO2002016598A2 (en) *	2000-08-22	2002-02-28	Agensys, Inc.	Nucleic acid and corresponding protein named 158p1h4 useful in the treatment and detection of bladder and other cancers
WO2002026826A2 (en) *	2000-09-27	2002-04-04	Curagen Corporation	Proteins and nucleic acids encoding same
AU1181802A (en)	2000-09-27	2002-04-08	Curagen Corp	Novel proteins and nucleic acids encoding same
US20020151695A1 (en) *	2000-11-28	2002-10-17	Shuqian Jing	Transforming growth factor-beta-related molecules and uses thereof
MXPA03008039A (en)	2001-03-08	2004-05-24	Immunex Corp	Human serpin polypeptides.
US6921807B2 (en)	2001-03-29	2005-07-26	Zymogenetics, Inc.	Proteinase inhibitor ZSERP9
US20020172995A1 (en) *	2001-05-17	2002-11-21	Wei Shao	Isolated human secreted proteins, nucleic acid molecules encoding human secreted proteins, and uses thereof
AU2002318513A1 (en) *	2001-07-06	2003-01-21	Nsgene A/S	Novel neurotrophic factors
US20030215852A1 (en) *	2002-04-01	2003-11-20	Wyeth	Novel pancortin-Pablo protein interactions and methods of use thereof
JP4429269B2 (en) *	2003-02-10	2010-03-10	大正製薬株式会社	Apoptosis-inducing genes and their use
AU2004210975B2 (en) *	2003-02-10	2008-04-10	Agensys, Inc.	Nucleic acid and corresponding protein named 158P1D7 useful in the treatment and detection of bladder and other cancers
JP2007532092A (en) *	2003-08-01	2007-11-15	ザイモジェネティクス，インコーポレイテッド	Adipocyte complement related protein ZACRP11
US7399469B2 (en)	2004-03-26	2008-07-15	Pdl Biopharma, Inc.	Anti-LFL2 antibodies for the diagnosis, prognosis and treatment of cancer
PT2887959T (en)	2012-08-23	2019-02-01	Seattle Genetics Inc	Antibody drug conjugates (adc) that bind to 158p1d7 proteins
US10828318B2 (en) *	2016-01-06	2020-11-10	Yeda Research And Development Co. Ltd.	Compositions and methods for treating malignant, autoimmune and inflammatory diseases
CN108178797B (en) *	2017-12-29	2020-12-01	西南大学	Polyclonal antiserum for resisting bombyx mori BmSRC, preparation method and application

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5830744A (en) *	1995-06-06	1998-11-03	Human Genome Sciences, Inc.	Gene encoding human Dnase
WO1995030428A1 (en) *	1994-05-05	1995-11-16	Human Genome Sciences, Inc.	Human dnase
AU3395900A (en) *	1999-03-12	2000-10-04	Human Genome Sciences, Inc.	Human lung cancer associated gene sequences and polypeptides

2001
- 2001-04-26 IL IL15241601A patent/IL152416A0/en unknown
- 2001-04-26 MX MXPA02010692A patent/MXPA02010692A/en unknown
- 2001-04-26 HU HU0300595A patent/HUP0300595A3/en unknown
- 2001-04-26 CA CA002407449A patent/CA2407449A1/en not_active Abandoned
- 2001-04-26 CZ CZ20023548A patent/CZ20023548A3/en unknown
- 2001-04-26 BR BR0110402-0A patent/BR0110402A/en not_active IP Right Cessation
- 2001-04-26 JP JP2001578451A patent/JP2003530869A/en not_active Withdrawn
- 2001-04-26 KR KR1020027014463A patent/KR20030032940A/en not_active Application Discontinuation
- 2001-04-26 CN CN01811752A patent/CN1439017A/en active Pending
- 2001-04-26 WO PCT/US2001/013360 patent/WO2001081363A1/en not_active Application Discontinuation
- 2001-04-26 PL PL01358580A patent/PL358580A1/en unknown
- 2001-04-26 AU AU2001257265A patent/AU2001257265A1/en not_active Abandoned
- 2001-04-26 EP EP01930760A patent/EP1276755A4/en not_active Withdrawn
2002
- 2002-10-25 NO NO20025151A patent/NO20025151L/en not_active Application Discontinuation
2003
- 2003-06-19 HK HK03104434.3A patent/HK1053840A1/en unknown

Also Published As

Publication number	Publication date
EP1276755A1 (en)	2003-01-22
CN1439017A (en)	2003-08-27
HK1053840A1 (en)	2003-11-07
NO20025151L (en)	2002-12-13
JP2003530869A (en)	2003-10-21
AU2001257265A1 (en)	2001-11-07
MXPA02010692A (en)	2003-03-10
CZ20023548A3 (en)	2003-05-14
IL152416A0 (en)	2003-05-29
HUP0300595A2 (en)	2003-06-28
CA2407449A1 (en)	2001-11-01
WO2001081363A1 (en)	2001-11-01
KR20030032940A (en)	2003-04-26
NO20025151D0 (en)	2002-10-25
HUP0300595A3 (en)	2007-06-28
EP1276755A4 (en)	2004-03-31
BR0110402A (en)	2003-02-11

Publication	Publication Date	Title
AU7476301A (en)	2002-01-02	Novel compounds
IL152416A0 (en)	2003-05-29	Novel compounds
GB0003019D0 (en)	2000-03-29	Novel compounds
AU9261901A (en)	2002-03-26	Novel compounds
EP1255771A4 (en)	2004-09-29	Novel compounds
GB0008464D0 (en)	2000-05-24	Novel compounds
EP1292617A4 (en)	2005-04-06	Novel compounds
EP1472352A4 (en)	2005-10-12	Novel compounds
EP1343813A4 (en)	2004-11-17	Novel compounds
AU7476401A (en)	2002-01-02	Novel compounds
EP1276866A4 (en)	2005-03-16	Novel compounds
GB0004149D0 (en)	2000-04-12	Novel compounds
EP1299530A4 (en)	2005-03-09	Novel compounds
GB0003636D0 (en)	2000-04-05	Novel compounds
GB0001898D0 (en)	2000-03-22	Novel compounds
GB0002402D0 (en)	2000-03-22	Novel compounds
GB0004196D0 (en)	2000-04-12	Novel compounds
EG22332A (en)	2002-12-31	Novel compounds
GB0008421D0 (en)	2000-05-24	Novel compounds
GB0002330D0 (en)	2000-03-22	Novel compounds
GB0006545D0 (en)	2000-05-10	Novel compounds
GB0004071D0 (en)	2000-04-12	Novel compounds
GB0001550D0 (en)	2000-03-15	Novel compounds
GB0006168D0 (en)	2000-05-03	Novel compounds
GB0006132D0 (en)	2000-05-03	Novel compounds